108 related articles for article (PubMed ID: 11957817)
1. [Overweight--problem in pediatric patients. Part I. Obesity as a risk factor for metabolic disturbances].
Chobot PJ; Buczkowska EO; Polańska J
Przegl Lek; 2001; 58(10):908-14. PubMed ID: 11957817
[TBL] [Abstract][Full Text] [Related]
2. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy.
Valerio G; Licenziati MR; Iannuzzi A; Franzese A; Siani P; Riccardi G; Rubba P
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):279-84. PubMed ID: 16679220
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of glucose intolerance in school age children. Population based cross-sectional study.
Mazur A; Grzywa M; Małecka-Tendera E; Telega G
Acta Paediatr; 2007 Dec; 96(12):1799-802. PubMed ID: 17953725
[TBL] [Abstract][Full Text] [Related]
5. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
6. Significance of acanthosis nigricans in childhood obesity.
Guran T; Turan S; Akcay T; Bereket A
J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
[TBL] [Abstract][Full Text] [Related]
7. Overweight, obesity and elevated blood pressure in children and adolescents.
Schiel R; Beltschikow W; Kramer G; Stein G
Eur J Med Res; 2006 Mar; 11(3):97-101. PubMed ID: 16751109
[TBL] [Abstract][Full Text] [Related]
8. Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors.
Burgert TS; Dziura J; Yeckel C; Taksali SE; Weiss R; Tamborlane W; Caprio S
Int J Obes (Lond); 2006 Feb; 30(2):273-80. PubMed ID: 16231019
[TBL] [Abstract][Full Text] [Related]
9. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
10. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
[TBL] [Abstract][Full Text] [Related]
11. [TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].
Goral J
Ann Acad Med Stetin; 2008; 54(2):14-21. PubMed ID: 19374226
[TBL] [Abstract][Full Text] [Related]
12. Obesity in Spanish schoolchildren: relationship with lipid profile and insulin resistance.
Garcés C; Gutierrez-Guisado J; Benavente M; Cano B; Viturro E; Ortega H; de Oya M
Obes Res; 2005 Jun; 13(6):959-63. PubMed ID: 15976136
[TBL] [Abstract][Full Text] [Related]
13. Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth.
Oliveira AC; Oliveira AM; Almeida MS; Silva AM; Adan L; Ladeia AM
J Pediatr; 2008 Mar; 152(3):337-42. PubMed ID: 18280837
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
15. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
[TBL] [Abstract][Full Text] [Related]
16. Metabolic characteristics of glucose intolerance: the critical role of obesity.
Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
[TBL] [Abstract][Full Text] [Related]
17. Use of glucose, insulin, and C-reactive protein to determine need for glucose tolerance testing.
Thompson WG; Bergstralh EJ; Slezak JM
Obes Res; 2003 Aug; 11(8):1027-32. PubMed ID: 12917509
[TBL] [Abstract][Full Text] [Related]
18. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
Sabuncu T; Ucar E; Birden F; Yasar O
Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
[TBL] [Abstract][Full Text] [Related]
19. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
[TBL] [Abstract][Full Text] [Related]
20. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
